Webinar: Bridging from Clinical Development to Commercialization: Supporting Patients

About the Webinar

Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase III clinical trial patients post approval? In today’s complex access and reimbursement landscape, preparing your patients for the transition from clinical trial to commercial product requires proactive planning and collaboration with multiple stakeholders. While managing patient access and affordability during this transition is achievable, it is essential to understand the necessary support systems and comply with the reporting regulations in various countries.

With years of experience supporting product launches in retail, specialty, and rare disease products, we will guide you through the crucial components every manufacturer must have to support trial patients transitioning to the commercial space. You will gain valuable insights into the key requirements, critical components, and how to effectively implement these strategies for success.

What You Will Learn

• Key considerations for successfully moving patients into commercial space.
• Best practices for building programs to support patients in their journey.
• Insights into measuring the success of these programs.

Who Should Attend?

This webinar is ideal for:

• Managers and leaders who are responsible for marketing, patient access and reimbursement, and safety reporting.
• Professionals working in operations, research and development, patient access, and medical information.

Unable to join? Register and you will receive the recording after the live session.

Further information: www.propharmagroup.com/webinars/bridging-from-clinical-development-to-commercialization-supporting-patients